Ensign Peak Advisors, Inc Arvinas, Inc. Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 24,920 shares of ARVN stock, worth $644,431. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,920

Previous 24,770 0.61%

Holding current value

$644,431

Previous $659,000 6.98%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.66 - $32.73 $3,549 - $4,909	150 Added 0.61%	24,920 $613,000
Q1 2024 May 14, 2024	SELL	$36.38 - $52.31 $45,475 - $65,387	-1,250 Reduced 4.8%	24,770 $1.02 Million
Q3 2023 Nov 13, 2023	BUY	$19.64 - $28.21 $41,244 - $59,241	2,100 Added 8.78%	26,020 $511,000
Q2 2023 Aug 14, 2023	BUY	$21.73 - $31.43 $16,297 - $23,572	750 Added 3.24%	23,920 $593,000
Q1 2023 May 15, 2023	SELL	$26.15 - $37.26 $2.16 Million - $3.07 Million	-82,475 Reduced 78.07%	23,170 $633,000
Q4 2022 Feb 13, 2023	BUY	$32.47 - $57.24 $371,781 - $655,398	11,450 Added 12.16%	105,645 $3.61 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $1.44 Million - $2 Million	34,403 Added 57.54%	94,195 $4.19 Million
Q2 2022 Aug 12, 2022	SELL	$36.01 - $74.24 $957,217 - $1.97 Million	-26,582 Reduced 30.78%	59,792 $2.52 Million
Q1 2022 May 16, 2022	BUY	$60.27 - $81.57 $282,184 - $381,910	4,682 Added 5.73%	86,374 $5.81 Million
Q4 2021 Feb 11, 2022	BUY	$65.85 - $96.21 $3.55 Million - $5.19 Million	53,952 Added 194.49%	81,692 $6.71 Million
Q3 2021 Nov 12, 2021	SELL	$73.2 - $107.87 $1.37 Million - $2.02 Million	-18,697 Reduced 40.26%	27,740 $2.28 Million
Q2 2021 Aug 13, 2021	BUY	$60.45 - $84.26 $2.5 Million - $3.49 Million	41,437 Added 828.74%	46,437 $3.58 Million
Q4 2020 Feb 12, 2021	BUY	$20.19 - $84.93 $100,950 - $424,650	5,000 New	5,000 $425,000

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.38B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Arvinas, Inc. Transaction History